Gastrointestinal Steering Committee Roster
The Gastrointestinal Steering Committee (GISC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult gastrointestinal cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The GISC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Cathy Eng, M.D., FACP
Vanderbilt University Ingram Cancer Center
Nashville, TN
Karyn A. Goodman, M.D., M.S.
Tisch Cancer Institute at Mount Sinai Hospital
New York, NY
Members
Carmen Allegra, M.D.
National Cancer Institute
Bethesda, MD
Rebecca Auer, M.D., M.Sc., FRCSC
The Ottawa Hospital Research Institute
Ottawa, ON, Canada
Jordan Berlin, M.D., Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Jonathan Bleeker, M.D.
University of South Dakota Medical Center
Sioux Falls, SD
Yun Shin Chun, M.D.
University of Texas MD Anderson Cancer Center
Houston, TX
Ryan B. Corcoran, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Boston, MA
Anjelica Q. Davis
Fight Colorectal Cancer
Springfield, MO
Thomas J. George, Jr., M.D., FACP
University of Florida
Gainesville, FL
Sharlene Gill, M.D., M.P.H.
University of British Columbia
Vancouver, BC, Canada
Katherine Guthrie, Ph.D., M.S.
Fred Hutchinson Cancer Research Center
Seattle, WA
Theodore S. Hong, M.D.
Massachusetts General Hospital
Boston, MA
Lisa A. Kachnic, M.D.
Columbia University Irving Medical Center
New York, NY
Hagen F. Kennecke, M.D., M.H.A., FRCPC
Providence Cancer Institute Franz Clinic
Portland, OR
Elise Kohn, M.D.
National Cancer Institute
Bethesda, MD
Andrew Lowy, M.D., FACS
University of California San Diego Moores Cancer Center
San Diego, CA
Harvey J. Mamon, M.D., Ph.D.
Brigham and Women's Hospital
Boston, MA
Jeffrey Meyerhardt, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA
Margaret M. Mooney, M.D., M.B.A.
National Cancer Institute
Bethesda, MD
Donna Niedzwiecki, Ph.D.
Duke University Medical Center
Durham, NC
Christopher O'Callaghan, Ph.D., D.V.M.
Queen's University
Kingston, ON, Canada
Eileen O'Reilly, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Philip Philip, M.D., Ph.D., FRCP
Karmanos Cancer Institute
Detroit, MI
Laura Porter, M.D., FASCO
Patient Advocate
Cheverly, MD
Lewis R. Roberts, M.B., CH.B., Ph.D.
Mayo Clinic
Rochester, MN
Lawrence V. Rubinstein, Ph.D.
National Cancer Institute
Bethesda, MD
Qian Shi, Ph.D.
Mayo Clinic
Rochester, MN
Terence Z. Wong, M.D., Ph.D.
Duke University Medical Center
Durham, NC
Gregory Yothers, Ph.D.
University of Pittsburgh
Pittsburgh, PA
NCI CCCT Program Director
Laurie Shuman Moss, Ph.D.
laurie.shumanmoss@nih.gov